Skip Navigation


Nucleic Acids Research Advance Access originally published online on July 10, 2008
Nucleic Acids Research 2008 36(15):e96; doi:10.1093/nar/gkn423
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (221K) Freely available
Right arrow Screen PDF (233K) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
36/15/e96    most recent
gkn423v2
gkn423v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Backliwal, G.
Right arrow Articles by Wurm, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Backliwal, G.
Right arrow Articles by Wurm, F. M.
Related Collections
Right arrow Recombinant DNA expression
Right arrow Ribosomes and Protein Translation
Right arrow DNA transfer
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2008, Vol. 36, No. 15 e96
© 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Methods Online

Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions

Gaurav Backliwal1, Markus Hildinger2, Sebastien Chenuet1, Sarah Wulhfard1, Maria De Jesus2 and Florian M. Wurm1,2,*

1Ecole Polytechnique Fédérale de Lausanne, Laboratory of Cellular Biotechnology, Institute of Bioengineering, Faculty of Life Sciences, Lausanne, Switzerland and 2ExcellGene SA, Monthey, Switzerland

*To whom correspondence should be addressed. Tel: +41 (0) 21 693 61 41; Fax: +41 (0) 21 693 61 40; Email: florian.wurm{at}epfl.ch

Received December 30, 2007. Revised June 17, 2008. Accepted June 18, 2008.

Transient transfection allows for fast production of recombinant proteins. However, the current bottlenecks in transient transfection are low titers and low specific productivity compared to stable cell lines. Here, we report an improved transient transfection protocol that yields titers exceeding 1 g/l in HEK293E cells. This was achieved by combining a new highly efficient polyethyleneimine (PEI)-based transfection protocol, optimized gene expression vectors, use of cell cycle regulators p18 and p21, acidic Fibroblast Growth Factor, exposure of cells to valproic acid and consequently the maintenance of cells at high cell densities (4 million cells/ml). This protocol was reproducibly scaled-up to a working volume of 2 l, thus delivering >1 g of purified protein just 2 weeks after transfection. This is the fastest approach to gram quantities of protein ever reported from cultivated mammalian cells and could initiate, upon further scale-up, a paradigm shift in industrial production of such proteins for any application in biotechnology.


The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.